MARKET

BDX

BDX

BECTON DICKINSN
NYSE

Real-time Quotes | Nasdaq Last Sale

253.82
-2.98
-1.16%
After Hours: 255.16 +1.34 +0.53% 16:56 09/23 EDT
OPEN
257.38
PREV CLOSE
256.80
HIGH
258.36
LOW
253.46
VOLUME
1.60M
TURNOVER
--
52 WEEK HIGH
267.37
52 WEEK LOW
219.50
MARKET CAP
72.89B
P/E (TTM)
39.86
1D
5D
1M
3M
1Y
5Y
BD Joins the Race to Zero: Largest Alliance Dedicated to Achieving Net Zero Emissions by 2050
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, with support from a number of partners including Global Citizen, is proud to announce the company has officially signed on to the Race to Zero via the most ambitio...
PR Newswire · 1d ago
Injectable Drug Delivery Market Influenza Diagnostics Market Research Report for Complete Analysis of Current Scenario 2020 – 2028
The scope of the report includes a detailed study of global and regional markets on Global Injectable Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.
Heraldkeepers · 2d ago
Flow Cytometry Market 2021-2025: Industry Analysis, Market Trends, Market Growth, Opportunities & Forecast
The Global Flow Cytometry Market is expected to exceed more than US$ 5.50 Billion by 2024 at a CAGR of 9.5% in the given forecast period.
Heraldkeepers · 2d ago
BRIEF-BD Partners With Washington State In Back-To-School Testing Effort
reuters.com · 2d ago
BD Partners with Washington State in Back-to-School Testing Effort
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of as a digitally read, rapid antigen test option for COVID-19 testing and screening in K-12 sch...
PR Newswire - PRF · 2d ago
Becton Dickinson to Provide COVID-19 Rapid Test Kits for Washington State Schools
MT Newswires · 2d ago
Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on
Zacks.com · 6d ago
UPDATE: $142M PIPE Deal Supporting Vicarious Surgical Business Includes Strategic Investments From Becton Dickinson And New Frontier Health Corporation
The total $142 million PIPE supporting the transaction is funded by multiple strategic investors including global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), major hospital groups
Benzinga · 09/15 20:53
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BDX. Analyze the recent business situations of BECTON DICKINSN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BDX stock price target is 267.80 with a high estimate of 285.00 and a low estimate of 250.00.
EPS
Institutional Holdings
Institutions: 1.96K
Institutional Holdings: 267.75M
% Owned: 93.23%
Shares Outstanding: 287.19M
TypeInstitutionsShares
Increased
544
13.38M
New
90
2.07M
Decreased
562
11.80M
Sold Out
115
2.43M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.88%
Healthcare Equipment & Supplies
+0.77%
Key Executives
Chairman/President/Chief Executive Officer/Chief Operating Officer/Director
Thomas Polen
Chief Financial Officer/Executive Vice President
Christopher DelOrefice
Corporate Executive
David Hickey
Chief Human Resource Officer/Executive Vice President/Director of Human Resources
Betty Larson
Executive Vice President/Chief Administrative Officer
Christopher Reidy
Executive Vice President
Simon Campion
Executive Vice President
Alexandre Conroy
Executive Vice President
Roland Goette
Executive Vice President
Samrat Khichi
Executive Vice President
James Lim
Executive Vice President
Alberto Mas
Chief Accounting Officer/Vice President/Controller
Thomas Spoerel
Lead Director/Independent Director
Marshall Larsen
Independent Director
Catherine Burzik
Independent Director
R. Andrew Eckert
Independent Director
Claire Fraser
Independent Director
Jeffrey Henderson
Independent Director
Christopher Jones
Independent Director
David Melcher
Independent Director
Claire Pomeroy
Independent Director
Rebecca Rimel
Independent Director
Timothy Ring
Independent Director
Bertram Scott
Declaration Date
Dividend Per Share
Ex-Div Date
07/27/2021
Dividend USD 0.83
09/08/2021
04/27/2021
Dividend USD 0.83
06/08/2021
01/25/2021
Dividend USD 0.83
03/09/2021
11/24/2020
Dividend USD 0.83
12/09/2020
07/27/2020
Dividend USD 0.79
09/08/2020
04/28/2020
Dividend USD 0.79
06/08/2020
01/27/2020
Dividend USD 0.79
03/09/2020
11/25/2019
Dividend USD 0.79
12/09/2019
07/22/2019
Dividend USD 0.77
09/06/2019
04/29/2019
Dividend USD 0.77
06/06/2019
01/21/2019
Dividend USD 0.77
03/07/2019
11/19/2018
Dividend USD 0.77
12/07/2018
07/24/2018
Dividend USD 0.75
09/06/2018
04/23/2018
Dividend USD 0.75
06/07/2018
01/23/2018
Dividend USD 0.75
03/08/2018
11/21/2017
Dividend USD 0.75
12/07/2017
07/27/2017
Dividend USD 0.73
09/07/2017
05/24/2017
Dividend USD 0.73
06/07/2017
01/24/2017
Dividend USD 0.73
03/08/2017
11/22/2016
Dividend USD 0.73
12/07/2016
About BDX
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Webull offers kinds of Becton Dickinson and Co stock information, including NYSE:BDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform.